BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2025 3:09:39 AM | Browse: 3 | Download: 32
Publication Name World Journal of Gastroenterology
Manuscript ID 105895
Country China
Received
2025-02-10 05:07
Peer-Review Started
2025-02-10 05:07
To Make the First Decision
Return for Revision
2025-03-26 03:06
Revised
2025-04-05 15:45
Second Decision
2025-05-21 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-05-21 05:22
Articles in Press
2025-05-21 05:22
Publication Fee Transferred
2025-04-07 13:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-05-30 09:14
Publish the Manuscript Online
2025-06-06 03:09
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Retrospective Study
Article Title Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients
Manuscript Source Unsolicited Manuscript
All Author List Xi Li, Fu-Long Song, Hai-Feng He, Shu-Min Zeng, Zhi-Chao Feng and Peng-Fei Rong
ORCID
Author(s) ORCID Number
Zhi-Chao Feng http://orcid.org/0000-0001-6651-5195
Peng-Fei Rong http://orcid.org/0000-0001-5473-1982
Funding Agency and Grant Number
Funding Agency Grant Number
the National Natural Science Foundation of China 82372072 and 82071986
Corresponding Author Peng-Fei Rong, Department of Radiology, The Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, Changsha 410013, Hunan Province, China. rongpengfei66@163.com
Key Words Crohn’s disease; Computed tomography enterography; Infliximab; Delta-radiomics; Secondary loss of response
Core Tip The treatment response to infliximab in patients with Crohn's disease (CD) is heterogeneous, with approximately 23%-46% of those achieving clinical remission after induction therapy experiencing secondary loss of response (SLR) within the first year. This significantly increases the risk of serious adverse outcomes. In this study, we developed a delta-radiomics model based on longitudinal changes in visceral adipose tissue assessed through computed tomography enterography. This model further integrates clinical and imaging biomarkers to identify patients with CD at high risk of SLR. This non-invasive approach holds promise as a valuable tool for optimizing personalized treatment regimens and guiding monitoring strategies.
Publish Date 2025-06-06 03:09
Citation <p>Li X, Song FL, He HF, Zeng SM, Feng ZC, Rong PF. Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients. <i>World J Gastroenterol</i> 2025; 31(21): 105895</p>
URL https://www.wjgnet.com/1007-9327/full/v31/i21/105895.htm
DOI https://dx.doi.org/10.3748/wjg.v31.i21.105895
Full Article (PDF) WJG-31-105895-with-cover.pdf
Manuscript File 105895_Auto_Edited_060542.docx
Answering Reviewers 105895-answering-reviewers.pdf
Audio Core Tip 105895-audio.mp3
Biostatistics Review Certificate 105895-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 105895-conflict-of-interest-statement.pdf
Copyright License Agreement 105895-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 105895-foundation-statement.pdf
Signed Informed Consent Form(s) or Document(s) 105895-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 105895-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 105895-non-native-speakers.pdf
Supplementary Material 105895-supplementary-material.pdf
Peer-review Report 105895-peer-reviews.pdf
Scientific Misconduct Check 105895-scientific-misconduct-check.png
Scientific Editor Work List 105895-scientific-editor-work-list.pdf
CrossCheck Report 105895-crosscheck-report.pdf